Altria Group (MO) Fair Value & Analysis
Consumer Defensive · US · Market cap $118B
Altria Group
MO · US
Fair value as of: Jun 24, 2026
From 22 valuation models · updated 8 days ago
Fair value updated Jun 24, 2026 — revised from $78.79 to $84.17 (+6.8%) since Jun 23, 2026. Share price +5.0% over the past month.
Price vs Fair Value (12 months)
12‑month range $53.00 – $73.42 · fair‑value band $65.52 – $106.99 · the $71.61 price screens below the $84.17 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Altria Group (MO) currently trades at $71.61, while our model-based Fair Value estimate is $84.17 — implying the stock looks roughly 17.5% undervalued today. We read business quality at 82/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Altria Group generated revenue of $20.4B at a net margin of 39.5%. Revenue grew 5.3% year over year. Net debt stands at $21.2B. The stock trades on a trailing P/E of 14.7. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. It offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and oral tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. The company sells its products to distributors, as well as large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Altria Group reported revenue of $20.1B in FY2025 versus $26.0B in FY2021, a compound −6.2%/yr. Reported net income was $6.9B in FY2025, compounding +29.4%/yr from FY2021.
Is MO fairly valued? → Check now
Recent news
- Dutch World Cup fans discover America’s biggest attraction: Its suburbs
- Social Security Pays $1,976 a Month. Here’s What a $393,000 Portfolio Generates Instead
- Philip Morris, Other Tobacco Stocks Rise After FDA Proposes Foreign Tobacco Regulations
- Is Altria (MO) Quietly Rewriting Its Investment Story With Smoke‑Free Bets Funded By Cigarettes?
External third-party headlines (Yahoo Finance, Reuters and others) — not an editorial selection, not financial advice.
Similar stocks
6 more Tobacco stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Philip Morris International Inc PM | $173.17 | $106.19 | -39% |
| British American Tobacco p.l.c. BTI | $60.46 | $25.74 | -57% |
| Japan Tobacco Inc JAPAF | $34.75 | $26.18 | -25% |
| ITC Limited ITC | ₹280.70 | ₹215.21 | -23% |
| Imperial Brands PLC IMBBY | $37.78 | $57.39 | +52% |
| KT&G Corporation 033780 | 185,100 KRW | 106,289 KRW | -43% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Altria Group (MO) undervalued?
What is the fair value of MO?
What is the quality score of MO?
What is the revenue of Altria Group (MO)?
What is the net profit margin of MO?
Does Altria Group pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.